Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 372

3EC International a.s.

Region/Country:  
  • Countries in the EU/EEA
  • Slovakia

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

Action Duchenne

Region/Country:  
  • EU/EEA

Type of Actor:

  • Patient Organisations
  • Regional/Local Patient Organisations

Development Stage:

  • Patient and Public Involvement

Conditions and Diseases:

  • Muscle and Skeletal Diseases

Additional information

Action Duchenne is a charity that supports families and individuals affected by Duchenne muscular dystrophy (DMD), a rare and progressive muscle-wasting condition.

AFM-Téléthon

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Patient Organisations
  • Regional/Local Patient Organisations

AFNOR Certification

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (Javna agencija Republike Slovenije za zdravila in medicinske pripomočke) (JAZMP)

Region/Country:  
  • Countries in the EU/EEA
  • Slovenia

Type of Actor:

  • Regulators
  • HTA Bodies
  • Medicines Agencies
  • National Medicines Agencies
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Additional information

According to the JAZMP Website: “In the Republic of Slovenia, HTA is currently not performed in a dedicated HTA institution. JAZMP is currently not an HTA competent authority, but is in the position to perform HTA-related tasks in pricing procedures as defined in Article 182 of the Medicinal Products Act (Uradni list RS [Official Gazette of the Republic of Slovenia], No. 17/14 and 66/19).” (https://www.jazmp.si/en/human-medicines/health-technology-assessment/)

All Wales Therapeutics and Toxicology Centre (AWTTC)

Region/Country:  
  • UK

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

Alliance for Regenerative Medicine (ARM)

Region/Country:  
  • Global

Type of Actor:

  • Networks
  • Other International Networks

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

ARM is an international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM represents the interests of 400+ members across 25 countries, including small and large companies, academic research institutions, major medical centers and patient groups.

Amgros

Region/Country:  
  • Countries in the EU/EEA
  • Denmark

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

ATMP Sweden

Region/Country:  
  • Countries in the EU/EEA
  • Sweden

Type of Actor:

  • Networks
  • European and Regional Networks

Development Stage:

  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

ATMP Sweden is a national network for activities on Advanced Therapy Medicinal Products (ATMPs)

Austrian agency for health and food safety (Österreichische Agentur für Gesundheit und Ernährungssicherheit) (AGES)

Region/Country:  
  • Countries in the EU/EEA
  • Austria

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • National Medicines Agencies
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts